We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Blood Gas Analyzer Focuses on Safety at POC

By LabMedica International staff writers
Posted on 29 Dec 2010
A new blood gas analyzer was designed specifically to be used at the point of care (POC).

The compact cobas b 123 is ideal for use in critical care units, emergency rooms, and other POC settings. More...
Easy to use and virtually maintenance free, it incorporates a number of important infection control features and ensures minimal downtime with reliable, clot-free operation.

The only manual maintenance step required for the new instrument is the replacement of consumables.
Its highly durable electronics and mechanics make it robust and reliable, ensuring minimal downtime and saving time required at the machine. Clot-free operation ensures that there is no unnecessary disruption to routine or waste of reagents.

The instrument requires minimal training of staff. With touch screen operation, the system guides the user through operational processes systematically. The press of a single button is all that is required to initiate sampling and measurement.

The new analyzer has many infection control and safety features. There are no exposed needles and the protected sample input area remains closed during operation and between samples. Infection control is further enhanced by the collection of waste in a sealed pack within the closed system. Password authorization ensures safe and appropriate use by locking the instrument to unauthorized/untrained users.

The cobas b 123 includes all important critical care parameters including blood gases, hematocrit, bilirubin, electrolytes, glucose, and lactate. To make interpretation of results as easy as possible, the large, color display screen presents unambiguous readings, with measurements that fall outside predefined acceptable limits highlighted clearly.

The need for scanning barcodes and swapping the consumables across instruments is made redundant by Smart chips on the consumables (sensors, fluid packs, and quality control--QC packs). Because sensors are separate from the fluid pack, the latter can be stored at room temperature. Inventory status is displayed clearly on the screen and step-by-step prompts guide the user through the changing of consumables.

The footprint of the analyzer for environments where there is limited space is reduced by the front loading feature. Data can be transferred across instruments using a simple media card.

The new cobas b 123 POC system is the latest blood gas analyzer from Roche (Basel, Switzerland). It is due to be launched in the UK and Ireland in February 2011.

Dr. Thomas Vering, head of the Roche global sensor program, commented, "Consolidation of important critical care tests on one system allows medical professionals in critical care and emergency settings to obtain rapid answers to a broad range of medical questions. The cobas b 123 is flexible and configurable to accommodate individual needs and with its intuitive operation and excellent connectivity options, it is ideal for use at the point of care.”

Related Links:
Roche



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.